✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Sudarshan Pharma Industries Ltd.

SUDARSHAN

Market Cap
₹656 Cr.
P/E
57.27

Sudarshan Pharma Industries Ltd.

  • Sudarshan Pharma Ind
  • Sakar Healthcare
  • Bharat Parenterals
FAQs on Sudarshan Pharma Industries Ltd. Shareprice

Sudarshan Pharma Ind has given better returns compared to its competitors.
Sudarshan Pharma Ind has grown at ~95.28% over the last 2yrs while peers have grown at a median rate of 19.64%

Yes, Sudarshan Pharma Ind is expensive.
Latest PE of Sudarshan Pharma Ind is 58.43, while 3 year average PE is 42.16.
Also latest EV/EBITDA of Sudarshan Pharma Ind is 20.13 while 3yr average is 17.22.

View FAQ's On Business
Growth Table
  • Sudarshan Pharma Industries Ltd.
  • Sakar Healthcare
  • Bharat Parenterals
Balance Sheet
  • Sudarshan Pharma Industries Ltd.
  • Sakar Healthcare
  • Bharat Parenterals
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Sudarshan Pharma Industries Ltd.
  • Sakar Healthcare
  • Bharat Parenterals
Cash Flow
  • Sudarshan Pharma Industries Ltd.
  • Sakar Healthcare
  • Bharat Parenterals
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Sudarshan Pharma Industries Ltd.
  • Sakar Healthcare
  • Bharat Parenterals
Quarterly Results
  • Sudarshan Pharma Industries Ltd.
  • Sakar Healthcare
  • Bharat Parenterals
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Sudarshan Pharma Industries Ltd. Financials

Balance sheet of Sudarshan Pharma Ind is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Sudarshan Pharma Ind is increasing.
Latest debt of Sudarshan Pharma Ind is ₹124 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹105 Crs.

Yes, profit is increasing.
The profit of Sudarshan Pharma Ind is ₹12.52 Crs for TTM, ₹11.46 Crs for Mar 2024 and ₹7.04 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sudarshan Pharma Ind latest dividend payout ratio is 10.26% and 3yr average dividend payout ratio is 10.26%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech